122 related articles for article (PubMed ID: 38616141)
1. Method to assess the need for re-planning HDR brachytherapy tandem and ring treatments.
Gray T; Cherian S; Amarnath S; Guo B; Xia P; Wilkinson A
Med Dosim; 2024 Apr; ():. PubMed ID: 38616141
[TBL] [Abstract][Full Text] [Related]
2. Stability of Intracavitary Applicator Placement for HDR Brachytherapy of Cervix Cancer.
Balsdon A; Timotin E; Hunter R; Diamond K
J Med Imaging Radiat Sci; 2019 Sep; 50(3):441-448. PubMed ID: 31311722
[TBL] [Abstract][Full Text] [Related]
3. Interfraction variations in doses at OARs during three-dimensional high dose rate brachytherapy planning of cervix cancer.
Dhaka S; Rajani A; Kumar HS; Sharma N; Jakhar SL; Harsh K
J Cancer Res Ther; 2023; 19(5):1136-1141. PubMed ID: 37787275
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric evaluation of image based brachytherapy using tandem ovoid and tandem ring applicators.
Rangarajan R
Rep Pract Oncol Radiother; 2018; 23(1):57-60. PubMed ID: 29348735
[TBL] [Abstract][Full Text] [Related]
5. Single versus multichannel applicator in high-dose-rate vaginal brachytherapy optimized by inverse treatment planning.
Bahadur YA; Constantinescu C; Hassouna AH; Eltaher MM; Ghassal NM; Awad NA
J Contemp Brachytherapy; 2015 Jan; 6(4):362-70. PubMed ID: 25834580
[TBL] [Abstract][Full Text] [Related]
6. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
[TBL] [Abstract][Full Text] [Related]
7. CT and MR image fusion of tandem and ring applicator using rigid registration in intracavitary brachytherapy planning.
Oinam AS; Tomar P; Patel FD; Singh L; Rai B; Bahl A
J Appl Clin Med Phys; 2014 Mar; 15(2):4206. PubMed ID: 24710430
[TBL] [Abstract][Full Text] [Related]
8. Can MRI-only replace MRI-CT planning with a titanium tandem and ovoid applicator?
Harkenrider MM; Patel R; Surucu M; Chinsky B; Mysz ML; Wood A; Ryan K; Shea SM; Small W; Roeske JC
Brachytherapy; 2018; 17(5):747-752. PubMed ID: 29945764
[TBL] [Abstract][Full Text] [Related]
9. Utrecht Interstitial Applicator Shifts and DVH Parameter Changes in 3D CT-based HDR Brachytherapy of Cervical Cancer.
Shi D; He MY; Zhao ZP; Wu N; Zhao HF; Xu ZJ; Cheng GH
Asian Pac J Cancer Prev; 2015; 16(9):3945-9. PubMed ID: 25987066
[TBL] [Abstract][Full Text] [Related]
10. The population percentile allowance method for determining systematic spatial error tolerances for temporary intensity modulated brachytherapy.
Hopfensperger KM; Adams QE; Kim Y; Wu X; Xu W; Patwardhan K; Flynn RT
Med Phys; 2023 Oct; 50(10):6469-6478. PubMed ID: 37643427
[TBL] [Abstract][Full Text] [Related]
11. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of dose differences between intracavitary applicators for cervical brachytherapy using knowledge-based models.
Kallis K; Mayadev J; Covele B; Brown D; Scanderbeg D; Simon A; Frisbie-Firsching H; Yashar CM; Einck JP; Mell LK; Moore KL; Meyers SM
Brachytherapy; 2021; 20(6):1323-1333. PubMed ID: 34607771
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric impact of applicator displacement on three-dimensional image-guided high-dose-rate brachytherapy treatments for cervical cancer.
Jayarathna S; Hoang M; Badkul R; Hoover A
J Contemp Brachytherapy; 2023 Oct; 15(5):334-343. PubMed ID: 38026073
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
Beriwal S; Kim H; Heron DE; Selvaraj R
Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
[TBL] [Abstract][Full Text] [Related]
15. Inter-Fractional Variations in Volume and Radiation Dose to the Organs at Risk, High-Risk Clinical Target Volume and Implication of Image-Guided Adaptive Planning During Intracavitary Brachytherapy of Carcinoma Cervix.
Patil G; Br KK; Narayanan G
Cureus; 2022 Jan; 14(1):e21503. PubMed ID: 35223279
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of dosimetric impact of inter-application and intra-application variations in fractionated high-dose-rate intra-cavitary brachytherapy of cervical cancer.
Pasha T; Hassan HN; Radhakrishna N; N MS; Varghese AS; Viswanath L; Valuvil NB; S S; H B G; Khaleel I; Palled SR; Thimmaiah N
J Contemp Brachytherapy; 2021 Dec; 13(6):627-632. PubMed ID: 35079248
[TBL] [Abstract][Full Text] [Related]
17. Interfraction dose deviation and catheter position in cervical interstitial and intracavitary image guided HDR brachytherapy.
Xu Y; Harris T; O'Farrell D; Cormack R; Lee L; King M; Buzurovic I
Med Dosim; 2022 Spring; 47(1):e1-e6. PubMed ID: 34702633
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy.
Meerschaert R; Nalichowski A; Burmeister J; Paul A; Miller S; Hu Z; Zhuang L
J Appl Clin Med Phys; 2016 Nov; 17(6):323-333. PubMed ID: 27929505
[TBL] [Abstract][Full Text] [Related]
19. Intra-fractional dosimetric analysis of image-guided intracavitary brachytherapy of cervical cancer.
Yan J; Zhu J; Chen K; Yu L; Zhang F
Radiat Oncol; 2021 Aug; 16(1):144. PubMed ID: 34348758
[TBL] [Abstract][Full Text] [Related]
20. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
